A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection

Autor: Christiane Petignat, Daniel Genné, Jacques Schrenzel, Gérard A. Schockmel, Patrick Francioli, Thomas Bregenzer, Daniel Pablo Lew, Ursula Flueckiger, Werner Zimmerli, Stéphan Juergen Harbarth, Frédérique Jacobs

Publikováno v: Clinical Infectious Diseases, vol. 39, no. 9, pp. 1285-92
Clinical Infectious Diseases, Vol. 39, No 9 (2004) pp. 1285-1292

Background. Oral combination therapy with fluoroquinolones plus rifampicin is a promising alternative to standard parenteral therapy for staphylococcal infections. Methods. In a multicenter, randomized trial, we compared the efficacy, safety, and len

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a524551c61c7ee9e310158fa71d808b4
https://pubmed.ncbi.nlm.nih.gov/15714434